efficacy of low dose, long-acting gonadotropin releasing hormone analogues (gnrh-a) compared with daily injections of short-acting gnrh-a in art cycles

نویسندگان

robabeh taheripanah

mohammad a karimzadeh

mohammad ghafourzadeh

چکیده

background: the retrieval of good quality oocytes that is accomplished with selection of the best induction ovulation protocol on the basis of patients condition, age and cause of infertility, is one of the most important aspects of art cycles. the objective was to evaluate the efficacy of low dose, long acting gnrh-a (decapeptyle) for pituitary desensitization and outcome of art compared to long protocol of short acting gnrh-a (busereline). materials and methods: in this randomized clinical trial that was performed at yazd ivf center, 60 patients with 61 cycles of art were included. patients with endometriosis or age > 40 were excluded in this study. using coh-et, patients were randomly divided into two groups. in group one, 30 patients received a single half dose of decapeptyle (1.87mg) in mid-luteal phase. in the other group, 31 patients received buserelin daily (0.5mg), starting from previous mid-luteal phase. this was reduced to 0.25mg from gonadotropin administration day and was continued until the day of hcg injection. in these groups, the number of oocytes, the fertilization, cleavage, pregnancy and cancellation rates were compared. results: in two groups, there was no case of cancellation due to premature lh surge. in group i, the mean number of gonadotropins was 27.5+4.2 ampoules while in the second group, it was 28.4±2.8 ampoules (p>0.05). 312 oocytes from group i and 294 oocytes from group ii were retrieved. oocyte quality in group ii was better than group i (84.3% vs 77.2%, p<0.05). in long-acting gnrh-a group fertilization rate was 81.9% versus 71.1%in group ii (p<0.01). however, embryo development in group i (85.6% vs 94.1%, p<0.05) was lower than group ii. although, pregnancy rate was 20% in group i which was higher than group ii (12.6%) but, there was no significant difference in cancellation, pregnancy rate and gonadotropins dose in two groups. conclusion: the low dose long acting gnrh-a is a useful method for pituitary suppression. low dose gnrh-a combined with gonadotropins permitted the retrieval of good quality oocytes and had no effect on oocytes. the fertilization and pregnancy rates with this method are acceptable and its cost and tolerance is valuable for patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of Low Dose, Long-acting Gonadotropin Releasing Hormone Analogues (GnRH-a) Compared with Daily Injections of Short-acting GnRH-a in ART Cycles

Background: The retrieval of good quality oocytes that is accomplished with selection of the best induction ovulation protocol on the basis of patients condition, age and cause of infertility, is one of the most important aspects of ART cycles. The objective was to evaluate the efficacy of low dose, long acting GnRH-a (Decapeptyle) for pituitary desensitization and outcome of ART compared to lo...

متن کامل

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles

INTRODUCTION The aim of the study was to compare the efficacy of half-dose, long-acting GnRH analogue (Diphereline) with Suprefact in IVF/ICSI (in vitro fertilization/intracytoplasmic sperm injection) cycles. MATERIAL AND METHODS In this randomized clinical trial performed in Royan Institute, 126 infertile women who were first time candidates for IVF/ICSI were enrolled. Patients were randomly...

متن کامل

Gonadotropin-releasing Hormone (gnrh) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of Gnrh Agonist during Controlled Ovarian Hyperstimulation and in Vitro Fertilization

Objective: Both gonadotropin-releasing hormone (GnRH) analogs and antagonists have been used for pituitary desensitization during controlled ovarian hyperstimulation (COH). We aimed to determine the minimum effective daily dose of GnRH antagonist in women undergoing COH. We also compared the efficiency of a GnRH antagonist and a GnRH agonist. Materials and Methods: Women undergoing in vitro fer...

متن کامل

TREATMENT OF PRECOCIOUS PUBERTY BY A LONG-ACTING GONADOTROPIN-RELEASING HORMONE ANALOGUE IN CHILDREN

The GnRH analogue has been shown to be effective in the treatment of precocious puberty when given as a daily subcutaneous injection. We studied the effectiveness of a long-acting GnRH analogue, Triptoreline, for the treatment of central precocity, by suppressing gonadotropin and estradiol secretion in three children with true precocious puberty. One month after single dose intramuscular i...

متن کامل

treatment of precocious puberty by a long-acting gonadotropin-releasing hormone analogue in children

the gnrh analogue has been shown to be effective in the treatment of precocious puberty when given as a daily subcutaneous injection. we studied the effectiveness of a long-acting gnrh analogue, triptoreline, for the treatment of central precocity, by suppressing gonadotropin and estradiol secretion in three children with true precocious puberty. one month after single dose intramuscular inject...

متن کامل

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding

Gonadotropin-releasing hormone (GnRH) regulates reproduction. The human GnRH receptor lacks a cytoplasmic carboxy-terminal tail but has amino acid sequence motifs characteristic of rhodopsin-like, class A, G protein-coupled receptors (GPCRs). This review will consider how recent descriptions of X-ray crystallographic structures of GPCRs in inactive and active conformations may contribute to und...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of reproductive biomedicine

جلد ۲، شماره ۱، صفحات ۲۹-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023